Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Meiosis I01:49

Meiosis I

194.0K
Meiosis is a carefully orchestrated set of cell divisions, the goal of which—in humans—is to produce haploid sperm or eggs, each containing half the number of chromosomes present in somatic cells elsewhere in the body. Meiosis I is the first such division, and involves several key steps, among them: condensation of replicated chromosomes in diploid cells; the pairing of homologous chromosomes and their exchange of information; and finally, the separation of homologous chromosomes by...
194.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stretching the structural envelope of imatinib to reduce β-amyloid production by modulating both β- and γ-secretase cleavages of APP.

Frontiers in chemistry·2024
Same author

Selective mycobacterial capture with ultraviolet-polymerized poly-dimethyldiallyl chloride functionalized surfaces.

Journal of materials science. Materials in medicine·2024
Same author

Study of Sonographic Indicators of Ovarian Reserves in Women With WHO-Defined Anovulatory Disorders.

Cureus·2024
Same author

Rational Development of a Small-Molecule Activator of CK1γ2 That Decreases C99 and Beta-Amyloid Levels.

ACS chemical biology·2023
Same author

Pregnancy in Rudimentary Horn.

Cureus·2023
Same author

Cost and outcomes of intercostal nerve cryoablation versus thoracic epidural following the Nuss procedure.

Journal of pediatric surgery·2023
Same journal

A Retrospective Analysis of Cardiac Anatomy in Patients Undergoing the Fontan Operation.

Cureus·2026
Same journal

A Narrative Review of the Potential Impact of Next-Generation Tobacco and Nicotine Products on Cardiovascular Health.

Cureus·2026
Same journal

A Prospective Comparative Study for the Evaluation of Digital Learning as an Academic Tool for MBBS Phase III Students.

Cureus·2026
Same journal

Crossing the Septum: May-Thurner Syndrome and Patent Foramen Ovale as a Dual Mechanism for Recurrent Ischemic Stroke.

Cureus·2026
Same journal

Physical Restraint Practices, Attitudes, and Ethical Perceptions Among Intensive Care Unit (ICU) Doctors and Nurses in Morocco: A Cross-Sectional Survey Highlighting the Training-Use Paradox.

Cureus·2026
Same journal

Reversible Rapidly Progressive Dementia Due to Cerebral Amyloid Angiopathy.

Cureus·2026
See all related articles

Related Experiment Video

Updated: Aug 17, 2025

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
09:03

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Published on: August 25, 2019

9.5K

Comparing Non-invasive Prenatal Testing With Invasive Testing for the Detection of Trisomy 21.

Rifat Mokhtar1, Punit Hans2, Anjana Sinha2

  • 1Obstetrics and Gynecology, Bhagwan Mahavir Institute of Medical Sciences, Pawapuri, IND.

Cureus
|December 14, 2022
PubMed
Summary
This summary is machine-generated.

Non-invasive prenatal testing (NIPT) accurately detects trisomy 21, showing 100% sensitivity and specificity. This highly effective test offers a valuable alternative to invasive procedures like amniocentesis for prenatal screening.

Keywords:
amniocentesiscell-free fetal dnadown syndromeniptnon-invasive prenatal testtrisomytrisomy 21

More Related Videos

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.2K
FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

36.9K

Related Experiment Videos

Last Updated: Aug 17, 2025

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
09:03

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Published on: August 25, 2019

9.5K
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.2K
FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

36.9K

Area of Science:

  • Maternal-fetal medicine
  • Genetics
  • Prenatal diagnostics

Background:

  • Non-invasive prenatal testing (NIPT) analyzes cell-free fetal DNA (cffDNA) in maternal blood for aneuploidy screening.
  • NIPT offers high sensitivity and specificity, becoming a popular alternative to traditional screening and invasive diagnostic tests.
  • Amniocentesis, the gold standard for prenatal diagnosis, is invasive and carries procedure-related risks.

Purpose of the Study:

  • To compare the performance of NIPT against amniocentesis in pregnancies with positive screening for fetal trisomy.
  • To evaluate the diagnostic accuracy of NIPT for trisomy 21.

Main Methods:

  • An analytic cross-sectional prospective study was conducted over 2.5 years.
  • 34 pregnant women with second-trimester positive screening for trisomy 21 were enrolled.
  • Participants underwent both NIPT and amniocentesis for comparison.

Main Results:

  • Out of 34 women, 31 underwent NIPT, and 28 confirmed trisomy 21 on both NIPT and amniocentesis.
  • NIPT demonstrated 100% sensitivity (95% CI: 87.66–100.00%) for trisomy 21.
  • NIPT exhibited 100% specificity (95% CI: 29.24–100.00%) for trisomy 21.

Conclusions:

  • Non-invasive prenatal testing (NIPT) demonstrates high performance and effectiveness in detecting fetal trisomy 21.
  • NIPT serves as a highly accurate prenatal screening tool, comparable to invasive diagnostic methods.
  • Further research is needed to optimize the clinical integration of NIPT.